market access Archives -

Gilead rescinds orphan status request for COVID-19 drug

https://pharmaphorum.com/news/gilead-rescinds-orphan-status-request-for-covid-19-drug/

FDA backs Glenmark’s rival to AZ’s blockbuster Farxiga

https://pharmaphorum.com/news/fda-tentatively-backs-glenmarks-farxiga-generic/

Digital therapeutics formularies five years away in US, say payers

https://pharmaphorum.com/news/digital-therapeutics-formularies-five-years-away-in-us-say-payers/

Discover who’s speaking at Real-World Evidence 2020: Rare Diseases and Innovative Therapies

https://pharmaphorum.com/events/discover-whos-speaking-at-real-world-evidence-2020-rare-diseases-and-innovative-therapies/

Vifor forges iron drug partnership with Fresenius in China

https://pharmaphorum.com/news/vifor-forges-iron-drug-partnership-with-fresenius-in-china/

NICE rejects MSD/Pfizer’s combination in untreated kidney cancer

https://pharmaphorum.com/news/nice-rejects-msd-pfizers-combination-in-untreated-kidney-cancer/

Novartis plots cardio trial in UK as London HQ opens

https://pharmaphorum.com/news/novartis-plots-cardio-trial-in-uk-as-london-hq-opens/

Real-World Evidence 2020: Rare Diseases and Innovative Therapies

https://pharmaphorum.com/events/real-world-evidence-2020-rare-diseases-and-innovative-therapies/

Sanofi’s Dupixent funded in Wales and Scotland for adolescents with eczema

https://pharmaphorum.com/news/sanofis-dupixent-funded-in-wales-and-scotland-for-adolescents-with-eczema/

Search